Basal cell carcinoma associated with orbital invasion: Clinical features and treatment options

Dermatologic Surgery

Volumn 32, Issue 3, 2006, Pages 442-446

  Meads, Shanna B ^a,b   Greenway, Hubert T ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b MS 112 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IMIQUIMOD; METHOTREXATE;

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CHEMOSURGERY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT METASTASIS; PRIORITY JOURNAL; PUNCH BIOPSY; SEX DIFFERENCE; SUN EXPOSURE; VOMITING;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; ORBIT; SKIN NEOPLASMS;

EID: 33645454901     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32088.x     Document Type: Article

References (27)

1. Carter DM. Basal cell carcinoma. In Fitzpatrick TB Freedberg IM Eisen AZ et al editors. Dermatology in general medicine 3rd ed. New York, NY McGraw-Hill 1987. p. 159.
2. Lang PG Maize JC. Basal cell carcinoma. In Rigel DS Friedman RF Dzubow LM Reintgen DS Bystryn JC Marks R editors. Cancer of the skin. Philadelphia, PA Elsevier Saunders 2005. p. 114 5.
3. Walling HW Fosko SW Geraminejad PA Whitaker DC Arpey CJ. Aggressive basal cell carcinoma presentation, pathogenesis, and management. Cancer Metast Rev 2004 23 389 402.
4. Cook BE Bartley GB. Treatment options and future prospects for the management of eyelid malignancies an evidence-based update. Ophthalmology 2001 108 2088 98.
5. Cook BE Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology 1999 106 746 50.
6. Carter KD Nerad JA Whitaker DC. Clinical factors influencing periocular surgical defects after Mohs micrographic surgery. Ophthal Plast Reconstr Surg 1999 15 83 91.
7. Malhotra R Huilgol SC Huynh NT Selva D. The Australian Mohs Database, Part I periocular basal cell carcinoma experience over 7 years. Ophthalmology 2004 111 624 30.
8. Arlette JP Carruthers A Threlfall WJ Warshawski LM. Basal cell carcinoma of the periocular region. J Cutan Med Surg 1998 2 205 8.
9. Wong VA Marshall JA Whitehead KJ et al. Management of periocular basal cell carcinoma with modified en face frozen section controlled excision. Ophthal Plast Reconstr Surg 2002 18 430 5.
10. Lang P Maize JC. Histologic evolution of recurrent basal cell carcinoma and treatment implication. J Am Acad Dermatol 1986 14 186 96.
11. Robinson J Fisher SG. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 2000 136 1318 24.
12. Robins P Rodriguez-Sains R Rabinovitz H Rigel D. Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol 1985 11 1203 7.
13. Howard GR Nerad JA Carter KD Whitaker DC. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol 1992 113 123 33.
14. Leibovitch I McNab A Sullivan T Davis G Selva D. Orbital invasion by periocular basal cell carcinoma. Opthalmology 2005 112 717 23.
15. Rathbun J Beard C Quickert MH. Evaluation of 48 cases of orbital exenteration. Am J Ophthalmol 1971 30 191 9.
16. Savage RC. Orbital exenteration and reconstruction for massive basal cell and squamous cell carcinoma of cutaneous origin. Ann Plast Surg 1983 10 458 66.
17. Barrett TL Greenway HT Jr. Massullo V Carlson C. Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion. Adv Dermatol 1993 8 277 304.
18. Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 1986 104 901 9.
19. Malhotra R Huilgol SC Huynh NT Selva D. The Australian Mohs Database, Part II periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology 2004 111 631 6.
20. Ben Simon GJ Schwarcz RM Douglas R Fiaschetti D McCann JD Goldberg RA. Orbital exenteration one size does not fit all. Am J Ophthalmol 2005 139 11 7.
21. Rosen HM. Periorbital basal cell carcinoma requiring ablative craniofacial surgery. Arch Dermatol 1987 123 376 8.
22. Fitzpatrick PJ Thompson GA Easterbrook WM Gallie BL Payne DG. Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy. Int J Radiat Oncol Biol Phys 1984 10 449 54.
23. Solan MJ Brady LW. Skin cancer. In Perez CA Brady LW Halperin EC Schmidt-Ullrich RK editors. Principles and practice of radiation oncology 4th edn. Philadelphia, PA Lippincott Williams & Wilkins 2004. p. 763 5.
24. Freire JE Brady LW Shields JA Shields CL. Eye and orbit. In Perez CA Brady LW Halperin EC Schmidt-Ullrich RK editors. Principles and practice of radiation oncology 4th edn. Philadelphia, PA Lippincott Williams & Wilkins 2004. p. 876 92.
25. Pfeiffer P Hanse O Rose C. Systemic cytotoxic therapy of basal cell carcinoma. A review of the literature. Eur J Cancer 1990 26 73 7.
26. Guthrie TH Porubsky ES Luxenberg MN Shah KJ Wurtz KL Watson PR. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol 1990 8 342 6.
27. Morley M Finger PT Perlin M Weiselberg LR Deblasio DS. Cis-platinum chemotherapy for ocular basal cell carcinoma. Br J Ophthalmol 1991 75 407 10.